[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 8, 2010

Bleeding Avoidance Strategies and Percutaneous Coronary Intervention—Reply

JAMA. 2010;304(10):1068-1069. doi:10.1001/jama.2010.1256

In Reply: We agree with the comments by Dr Huang and colleagues. Our principal findings were the association of both bivalirudin and vascular closure devices with lower rates of periprocedural bleeding, and the apparent risk-treatment paradox with regard to individual preprocedure bleeding risk and use of these therapies in clinical practice. Because this was an observational study of clinical registry data, we attempted to avoid causal language in describing the association between the use of vascular closure devices and bivalirudin with periprocedural bleeding throughout the article.

First Page Preview View Large
First page PDF preview
First page PDF preview
×